Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Life Sciences|January 1, 1997
The effects of propofol on cerebral high energy metabolites, lactate, and glucose in normoxic and severely hypoxic ratsC Ori, L Cavallini, U Freo, et al.
Transplantation Proceedings|May 23, 2009
Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patientsM Senzolo, G Pizzolato, C Ferronato, et al.
Neurology|October 1, 1996
Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZMG Pizzolato, F Chierichetti, M Fabbri, et al.
Neuroradiology|September 8, 1998
Epidermoid cyst of the skull with nonpulsatile tinnitusM Piotin, P Gailloud, A Reverdin, et al.
European Neurology|January 1, 1990
Regional cerebral blood flow study with 99mTc-hexamethyl-propyleneamine oxime single photon emission computed tomography in Alzheimer's and multi-infarct dementiaL Battistin, G Pizzolato, M Dam, et al.
Acta Neurologica Scandinavica|March 1, 1994
Single photon emission computed tomography with [99Tc]-HM-PAO and [123I]-IBZM in Alzheimer's disease and dementia of frontal type: preliminary resultsG B Frisoni, G Pizzolato, A Bianchetti, et al.
Clinical Neuropathology|December 9, 2004
Malignant transformation of a spinal cord ganglioglioma--case report and review of the literatureP L Di Patre, M Payer, M Brunea, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 1, 1995
Cerebral metabolic responses to clomipramine are greatly reduced following pretreatment with the specific serotonin neurotoxin para-chloroamphetamine (PCA). A 2-deoxyglucose study in ratsU Freo, P Pietrini, G Pizzolato, et al.
European Journal of Gastroenterology & Hepatology|August 19, 2004
Does liver-disease aetiology have a role in cerebral blood-flow alterations in liver cirrhosis?P Burra, M Senzolo, G Pizzolato, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson's disease: a [123I]-IBZM SPET studyG Pizzolato, F Chierichetti, A Rossato, et al.
Pageof 6